NCT07018570: An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 26 planned
- Started
- 24 Jul 2025
- Primary completion
- Jun 2030
- Arms
- Pembrolizumab plus FLOT, Ratiation
- Results
- None posted
- 12 Jun 2025: Trial registered
- 24 Jul 2025: Trial started